Tech Company Financing Transactions
Sweet Bio Funding Round
On 6/30/2015, Sweet Bio announced $50 thousand in funding from Innova Memphis and MB Venture Partners.
Transaction Overview
Company Name
Announced On
6/30/2015
Transaction Type
Venture Equity
Amount
$50,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
285 W Bdwy.
New York, NY 10013
USA
New York, NY 10013
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
SolveBio delivers the critical reference data used by hospitals and companies to run genomic applications. These applications use SolveBio's data to predict the effects of slight DNA variants on a person's health.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Mark Kaganovich
Chief Scientific Officer
Dandan Xu
Chief Technical Officer
David Caplan
Browse more venture capital transactions:
Prev: 6/30/2015: VidSys venture capital transaction
Next: 6/30/2015: Envisia Therapeutics venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. All VC database entries reported here are derived from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs